Genetics of Dilated Cardiomyopathy

Heart Failure Clinics

Volumn 6, Issue 2, 2010, Pages 129-140

  Fatkin, Diane ^a,b,c   Otway, Robyn ^a   Richmond, Zara ^a  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dilated cardiomyopathy; Genetics; Heart failure

Indexed keywords

ACTIN; AMINO ACID; CALCIUM ION; COLLAGEN; GAMMA SECRETASE; MYOSIN; NUCLEAR PROTEIN; TROPOMYOSIN; TROPONIN;

ANGER; ANXIETY; APOPTOSIS; ATRIOVENTRICULAR CONDUCTION; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BIOINFORMATICS; CALCIUM METABOLISM; CELL SURVIVAL; CHROMOSOME; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CYTOSKELETON; DEPRESSION; DNA MICROARRAY; DNA POLYMORPHISM; DNA SEQUENCE; DOPPLER ECHOGRAPHY; DROSOPHILA; DYSPNEA; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FAMILY HISTORY; FATIGUE; FEAR; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEGREGATION; GENETIC CODE; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC SCREENING; GENETICS; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GUILT; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART PALPITATION; HEART PERFORMANCE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART TRANSPLANTATION; HOMEOSTASIS; IN VITRO STUDY; INTRON; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; MISSENSE MUTATION; MITOCHONDRION; MITRAL VALVE PROLAPSE; MUTAGENESIS; MYOFILAMENT; ONSET AGE; PATHOGENESIS; PATIENT EDUCATION; PERCEPTION DEAFNESS; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PROGENY; PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; RNA SPLICING; SARCOMERE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; THIN FILAMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; WILD TYPE; X CHROMOSOME LINKED DISORDER; ZEBRA FISH;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEART FAILURE; HUMANS; PHENOTYPE; THROMBOEMBOLISM;

EID: 77949907070     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2009.11.003     Document Type: Review

References (108)

1. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies. Circulation 113 14 (2006) 1807-1816
2. Fatkin D., and Graham R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82 4 (2002) 945-980
3. Fatkin D., MacRae C., Sasaki T., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341 23 (1999) 1715-1724
4. Brodsky G.L., Muntoni F., Miocic S., et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101 5 (2000) 473-476
5. Genschel J., Baier P., Kuepferling S., et al. A new frameshift mutation at codon 466 (1397delA) within the LMNA gene. Hum Mutat 16 3 (2000) 278
6. Genschel J., Bochow B., Kuepferling S., et al. A R644C mutation within lamin A extends the mutations causing dilated cardiomyopathy. Hum Mutat 17 2 (2001) 154
7. Jakobs P.M., Hanson E.L., Crispell K.A., et al. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail 7 3 (2001) 249-256
8. Arbustini E., Pilotto A., Repetto A., et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 39 6 (2002) 981-990
9. Hershberger R.E., Hanson E.L., Jakobs P.M., et al. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for a permanent pacemaker. Am Heart J 144 6 (2002) 1081-1086
10. Taylor M.R.G., Fain P.R., Sinagra G., et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41 5 (2003) 771-780
11. Sebillon P., Bouchier C., Bidot L.D., et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 40 8 (2003) 560-567
12. MacLeod H.M., Culley M.R., Huber J.M., et al. Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Med Genet 4 (2003) 4
13. Verga L., Concardi M., Pilotto A., et al. Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects. Virchows Arch 443 5 (2003) 664-671
14. Vytopil M., Benedetti S., Ricci E., et al. Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet 40 12 (2003) e132
15. Hermida-Prieto M., Monserrat L., Castro-Beiras A., et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 94 1 (2004) 50-54
16. Pethig K., Genschel J., Peters T., et al. LMNA mutations in cardiac transplant recipients. Cardiology 103 2 (2005) 57-62
17. Otomo J., Kure S., Shiba T., et al. Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene. J Cardiovasc Electrophysiol 16 2 (2005) 137-145
18. Sylvius N., Bilinska Z.T., Veinot J.P., et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 42 8 (2005) 639-647
19. Karkkainen S., Reissell E., Helio T., et al. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart 92 4 (2006) 524-526
20. Wang H., Wang J., Zheng W., et al. Mutation Glu82Lys in lamin A/C gene is associated with cardiomyopathy and conduction defect. Biochem Biophys Res Commun 344 1 (2006) 17-24
21. Perrot A., Sigusch H.H., Nagele H., et al. Genetic and phenotypic analysis of dilated cardiomyopathy with conduction-system disease: demand for strategies in the management of presymptomatic lamin A/C mutant carriers. Eur J Heart Fail 8 5 (2006) 484-493
22. Song K., Dube M.P., Lim J., et al. Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy. Exp Mol Med 39 1 (2007) 114-120
23. Van Tintelen J.P., Hofstra R.M.W., Katerberg H., et al. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 154 6 (2007) 1130-1139
24. Geiger S.K., Bar H., Ehlermann P., et al. Incomplete nonsense-mediated decay of mutant lamin A/C RNA provokes dilated cardiomyopathy and ventricular tachycardia. J Mol Med 86 3 (2008) 281-289
25. Fujimori Y., Okimatsu H., Kashiwagi T., et al. Molecular defects associated with antithrombin deficiency and dilated cardiomyopathy in a Japanese patient. Intern Med 47 10 (2008) 925-931
26. Li D., Parks S.B., Kushner J.D., et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet 79 6 (2006) 1030-1039
27. Kamisago M., Sharma S.D., DePalma S.R., et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343 23 (2000) 1688-1696
28. Li D., Czernuszewicz G.Z., Gonzalez O., et al. Novel cardiac troponin T mutations as a cause of familial dilated cardiomyopathy. Circulation 104 18 (2001) 2188-2193
29. Mogensen J., Murphy R.T., Shaw T., et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 44 10 (2004) 2033-2040
30. Stefanelli C.B., Rosenthal A., Borisov A.B., et al. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependent severity. Mol Genet Metab 83 1-2 (2004) 188-196
31. Mohapatra B., Jimenez S., Lin J.H., et al. Mutations in the muscle LIM protein and α-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 80 1-2 (2003) 207-215
32. Arimura T., Hayashi T., Matsumoto Y., et al. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochem Biophys Res Commun 357 1 (2007) 162-167
33. Jung M., Poepping I., Perrot A., et al. Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. Am J Hum Genet 65 4 (1999) 1068-1077
34. Gerull B., Gramlich M., Atherton J., et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30 2 (2002) 201-204
35. Itoh-Satoh M., Hayashi T., Nishi H., et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 291 2 (2002) 385-393
36. Gerull B., Atherton J., Geupel A., et al. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. J Mol Med 84 6 (2006) 478-483
37. Li D., Tapscoft T., Gonzalez O., et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100 5 (1999) 461-466
38. Kostareva A., Gudkova A., Sjoberg G., et al. Desmin mutations in a St Petersburg cohort of cardiomyopathies. Acta Myol 25 3 (2006) 109-115
39. Taylor M.R.G., Slavov D., Ku L., et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 115 10 (2007) 1244-1251
40. Bergman J.E., Veenstra-Knol H.E., Van Essen A.J., et al. Two related Dutch families with a clinically variable presentation of cardioskeletal myopathy caused by a novel S13F mutation in the desmin gene. Eur J Med Genet 50 5 (2007) 355-366
41. McNair W.P., Ku L., Taylor M.R.G., et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110 15 (2004) 2163-2167
42. Olson T.M., Michels V.V., Ballew J.D., et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293 4 (2005) 447-454
43. Lim C.C., Yang H., Yang M., et al. A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys J 94 9 (2008) 3577-3589
44. Tsubata S., Bowles K.R., Vatta M., et al. Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106 5 (2000) 655-662
45. Karkkainen S., Miettinen R., Tuomainen P., et al. A novel mutation, Arg71Thr, in the δ-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med 81 12 (2003) 795-800
46. Sylvius N., Tesson F., Gayet C., et al. A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16. Am J Hum Genet 68 1 (2001) 241-246
47. Knoll R., Postel R., Wang J., et al. Laminin-α4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 116 5 (2007) 515-525
48. Schmidt J.P., Kamisago M., Asahi M., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299 5611 (2003) 1410-1413
49. Haghighi K., Kolokathis F., Pater L., et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111 6 (2003) 869-876
50. Haghighi K., Kolokathis F., Gramolini A.O., et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A 103 5 (2006) 1388-1393
51. Messina D.N., Speer M.C., Pericak-Vance M.A., et al. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 61 4 (1997) 909-917
52. Schonberger J., Wang L., Shin J.T., et al. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet 37 4 (2005) 418-422
53. Schonberger J., Kuhler L., Martins E., et al. A novel locus for autosomal dominant dilated cardiomyopathy maps to chromosome 7q22.3-31.1. Hum Genet 118 3-4 (2005) 451-457
54. Zhang L., Hu A., Yuan H., et al. A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy. Circulation 102 11 (2008) 1426-1432
55. Krajinovic M., Pinamonti B., Sinagra G., et al. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet 57 4 (1995) 846-852
56. Duboscq-Bidot L., Xu P., Charron P., et al. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc Res 77 1 (2008) 118-125
57. Bowles K.R., Gajarski R., Porter P., et al. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest 98 6 (1996) 1355-1360
58. Olson T.M., Illenberger S., Kishimoto N.Y., et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105 4 (2002) 431-437
59. Vatta M., Mohapatra B., Jimenez S., et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42 11 (2003) 2014-2027
60. Arimura T., Hayashi T., Terada H., et al. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 279 8 (2004) 6746-6752
61. Ellinor P.T., Sasse-Klaassen S., Probst S., et al. A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26. J Am Coll Cardiol 48 1 (2006) 106-111
62. Daehmlow S., Erdmann J., Knueppel T., et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 298 1 (2002) 116-120
63. Knoll R., Hoshijima M., Hoffman H.M., et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111 7 (2002) 943-955
64. Inagaki N., Hayashi T., Arimura T., et al. αβ-Crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun 342 2 (2006) 379-386
65. ATP channel gating. Nat Genet 36 4 (2004) 382-387
66. Taylor M.R.G., Slavov D., Gajewski A., et al. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat 26 6 (2005) 566-574
67. Carniel E., Taylor M.R.G., Sinagra G., et al. α-myosin heavy chain. A sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112 1 (2005) 54-59
68. Karkkainen S., Helio T., Jaaskelainen P., et al. Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail 6 7 (2004) 861-868
69. Villard E., Duboscq-Bidot L., Charron P., et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 26 8 (2005) 794-803
70. Olson T.M., Michels V.V., Thibodeau S.N., et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280 5364 (1998) 750-752
71. Olson T.M., Kishimoto N.Y., Whitby F.G., et al. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33 4 (2001) 723-732
72. Hayashi T., Arimura T., Itoh-Satoh M., et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44 11 (2004) 2191-2201
73. Murphy R.T., Mogensen J., Shaw A., et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 363 9406 (2004) 371-372
74. Gold R., Kress W., Meurers B., et al. Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis. Muscle Nerve 15 2 (1992) 214-218
75. Muntoni F., Cau M., Ganau A., et al. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329 13 (1993) 921-925
76. Piccolo G., Azan G., Tonin P., et al. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy. Neuromuscul Disord 4 2 (1994) 143-146
77. Milasin J., Muntoni F., Severini G.M., et al. A point mutation in the 5′ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 5 1 (1996) 73-79
78. Bies R.D., Maeda M., Roberds S.L., et al. A 5′ dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. J Mol Cell Cardiol 29 12 (1997) 3175-3188
79. Muntoni F., Di Lenarda A., Porcu M., et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart 78 6 (1997) 608-612
80. Ortiz-Lopez R., Li H., Su J., et al. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 95 10 (1997) 2434-2440
81. Ferlini A., Galie N., Merlini L., et al. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet 63 2 (1998) 436-446
82. Yoshida K., Nakamura A., Yazaki M., et al. Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum Mol Genet 7 7 (1998) 1129-1132
83. Arbustini E., Diegoli M., Morbini P., et al. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35 7 (2000) 1760-1768
84. Franz W.M., Muller M., Muller O.J., et al. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet 355 9217 (2000) 1781-1785
85. Bastianutto C., Bestard J.A., Lahnakoski K., et al. Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum Mol Genet 10 23 (2001) 2627-2635
86. Tasaki N., Yoshida K., Haruta S.I., et al. X-linked dilated cardiomyopathy with a large hot-spot deletion in the dystrophin gene. Intern Med 40 12 (2001) 1215-1221
87. Feng J., Yan J., Buzin C.H., et al. Comprehensive mutation screening of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy. J Am Coll Cardiol 40 6 (2002) 1120-1124
88. Feng J., Yan J., Buzin C.H., et al. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol Genet Metab 77 1-2 (2002) 119-126
89. Kimura S., Ikezawa M., Ozasa S., et al. Novel mutation in splicing donor of dystrophin gene first exon in a patient with dilated cardiomyopathy but no clinical signs of skeletal myopathy. J Child Neurol 22 7 (2007) 901-906
90. Taylor M.R.G., Ku L., Slavov D., et al. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet 52 (2007) 830-835
91. George R.A., Liu J.Y., Feng L.L., et al. Analysis of protein sequence and interaction data for candidate disease gene prediction. Nucleic Acids Res 34 19 (2006) e130
92. Wolf M.J., Amrein H., Izatt J.A., et al. Drosophila as a model for the identification of genes causing adult human heart disease. Proc Natl Acad Sci U S A 103 5 (2006) 1394-1399
93. Taghli-Lamallem O., Akasaka T., Hogg G., et al. Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype. Aging Cell 7 2 (2008) 237-249
94. Hodges E., Xuan Z., Balija V., et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 39 12 (2007) 1522-1527
95. Reed G.H., Kent J.O., and Wittwer C.T. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics 8 6 (2007) 597-608
96. Francis G.S., and Tang W.H. Pathophysiology of congestive heart failure. Rev Cardiovasc Med 4 Suppl 2 (2003) S14-S20
97. Le Corvoisier P., Park H.Y., Carlson K.M., et al. Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy. Hum Mol Genet 12 23 (2003) 3097-3107
98. Kushner J.D., Nauman D., Burgess D., et al. Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy. J Card Fail 12 6 (2006) 422-429
99. Burkett E.L., and Hershberger R.E. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45 7 (2005) 969-981
100. Baig M.K., Goldman J.H., Caforio A.L.P., et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 31 1 (1998) 195-201
101. Crispell K.A., Wray A., Ni H., et al. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy. J Am Coll Cardiol 34 3 (1999) 837-847
102. Michels V.V., Olson T.M., Miller F.A., et al. Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy. Am J Cardiol 91 1 (2003) 1389-1392
103. Mahon N.G., Murphy R.T., MacRae C.A., et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 143 2 (2005) 108-115
104. Caforio A.L.P., Mahon N.G., Baig M.K., et al. Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115 1 (2007) 76-83
105. McKenna C.J., Sugrue D.D., Kwon H.M., et al. Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathy. Am J Cardiol 83 1 (1999) 281-283
106. Mahon N.G., Sharma S., Elliott P.M., et al. Abnormal cardiopulmonary exercise variables in asymptomatic relatives of patients with dilated cardiomyopathy who have left ventricular enlargement. Heart 83 5 (2000) 511-517
107. Mahon N.G., Madden B.P., Caforio A.L.P., et al. Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 39 3 (2002) 455-462
108. Matsumura Y., Elliott P.M., Mahon N.G., et al. Familial dilated cardiomyopathy: assessment of left ventricular systolic and diastolic function using Doppler tissue imaging in asymptomatic relatives with left ventricular enlargement. Heart 92 3 (2006) 405-406